CONFERENCE COVERAGE SERIES
Society for Neuroscience Annual Meeting 2019
19 – 23 October 2019
Organized around 10 major themes, this year’s annual meeting attracted almost 23,000 scientists. Sessions in the Neurodegenerative Disorders and Injury theme drew the largest crowd, featuring more than 2,700 of SfN’s total 14,000-plus presentations. Aβ, tau, and other protein pathologies dominated, but there was a renewed emphasis on gene therapy for neurological disorders. Tom Fagan brings you some highlights.
Not Just Blood Pressure—Dietary Salt Linked to Tau Phosphorylation
Cognitive deficits in mice on a high-salt diet are due to tau phosphorylation, not reduced blood flow, according to a new study.
Time to Try Again: Gene-Based Therapy for Neurodegeneration
Encouraged by success in treating infant spinomuscular atrophy, researchers are redoubling their efforts to target genetic causes of age-related neurodegeneration.
Gene Therapies Enter Trials for Many Brain Pathologies—What about AD?
As gene therapy is making a comeback, scientists are exploring if it might prevent or reverse Alzheimer’s. Some of those treatments are permanent, heightening safety concerns.